Abstract
Relapsing polychondritis (RP) is a rare immune-mediated disease which is associated with inflammation in cartilaginous tissue throughout the body. Especially, the cartilaginous structures of ear, respiratory tract, nose, and joints are affected. Around 30% of the cases are associated with other diseases especially systemic vasculitis. Onset of RP is most likely between the ages of 40–60 years. This case reports the often disguised and similar symptoms of RP to Wegner’s granulomatosis and the challenge of diagnosis. The relative rarity of RP has not permitted clinical trials to determine the efficacy and safety of different therapies. Current treatment is largely empiric and based on case reports. In this case, we successfully used a treatment with the TNF-alpha antagonist adalimumab.
This is a preview of subscription content, log in via an institution to check access.
References
McAdam LP, O’Hanlan MA, Bluestone R et al (1976) Relapsing polychondritis: prospective study of 23 patients and a review of the literature. Medicine 55:193–215
Kent PD, Michet CJ, Luthra HS (2004) Relapsing polychondritis. Curr Opin Rheumatol 16:56–61
Leroux G, Costedoat-Chalumeau N, Brihaye B et al (2009) Treatment of relapsing polychondritis with rituximab: a retrospective study of nine patients. Arthritis Rheum 5:577–582
Damiani JM, Levine HL (1979) Relapsing polychondritis—report of ten cases. Laryngoscope 89:929–946
Foidart JM, Abe S, Martin GR et al (1978) Antibodies to type II collagen in relapsing polychondritis. N Engl J Med 299:1203–1207
Hansson AS, Heinegard D, Piette JC et al (2001) The occurrence of autoantibodies to matrilin 1 reflects a tissue-specific response to cartilage of the respiratory tract in patients with relapsing polychondritis. Arthritis Rheum 44:2402–2412
Hansson AS, Holmdahl R (2002) Cartilage-specific autoimmunity in animal models and clinical aspects in patients—focus on relapsing polychondritis. Arthritis Res 4:296–301
Piette JC, El-Rassi R, Amoura Z (1999) Antinuclear antibodies in relapsing polychondritis. Ann Rheum Dis 58:656–657
Lee KS, Ernst A, Trentham DE (2006) Relapsing polychondritis: prevalence of expiratory CT airway abnormalities. Radiology 240:565–573
Hashimoto K, Arkin CR, Kang AH (1977) Relapsing polychondritis: an ultrastructural study. Arthritis Rheum 20:91–99
Riccieri V, Spadoro A, Taccari E, Zoppini A (1988) A case of relapsing polychondritis: pathogenetic considerations. Clin Exp Rheumatol 6:95–96
Richez C, Dumoulin C, Coutouly X, Schaeverbeke T (2004) Successful treatment of relapsing polychondritis with infliximab. Clin Exp Rheumatol 22:629–631
Mpofu S, Estrach C, Curtis J, Moots RJ (2003) Treatment of respiratory complications in recalcitrant relapsing polychondritis with infliximab. Rheumatology 42:1117–1118
Carter JD (2005) Treatment of relapsing polychondritis with a TNF alpha antagonist. J Rheumatology 32:1413
Disclosures
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lahmer, T., Knopf, A., Treiber, M. et al. Treatment of relapsing polychondritis with the TNF-alpha antagonist adalimumab. Clin Rheumatol 29, 1331–1334 (2010). https://doi.org/10.1007/s10067-010-1488-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-010-1488-1